Image
24.05.2021
Diabetes UK seeks new Clinical Champions in Northern Ireland
Diabetes UK is urging healthcare professionals who are committed to transforming care for people living w...
customer support
customer support
From research findings supporting SGLT-2 inhibitors as a first-choice type 2 treatment to a real-world study strengthening evidence for teplizumab in early type 1, here are some of the diabetes research developments announced in February 2026.
Read more